Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Cardiac ablation industry 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Approach trends
2.1.4 Application trends
2.1.5 End-use trends
2.1.6 Regional trends
Chapter 3 Cardiac Ablation Industry Insights
3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry ecosystem analysis
3.2.1 Vendor matrix
3.2.2 Distribution channel analysis
3.2.3 Profit margin trends
3.3 Pricing analysis 2018 – 2032
3.3.1 Pricing analysis, by region
3.3.1.1 North America
3.3.1.2 Europe
3.3.1.3 Asia Pacific
3.3.1.4 Latin America
3.3.1.5 Middle East & Africa
3.4 Industry impact forces
3.4.1 Growth drivers
3.4.1.1 Increasing number of patients suffering from cardiovascular diseases including cardiac arrhythmias
3.4.1.2 Rising demand for minimally invasive procedures
3.4.1.3 Technological advancements in cardiac ablation devices
3.4.2 Industry pitfalls & challenges
3.4.2.1 High risk associated with cardiac ablation procedures
3.4.2.2 Stringent regulatory scenario
3.5 Growth potential analysis
3.5.1 By product
3.5.2 By approach
3.5.3 By application
3.5.4 By end-use
3.6 COVID- 19 impact analysis
3.7 Regulatory landscape
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.1.1 AngioDynamics, Inc.
4.1.2 AtriCure Inc
4.1.3 Biosense Webster
4.2 Competitive dashboard, 2021
4.3 Company market share, 2021
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Cardiac Ablation Market, By Product
5.1 Key segment trends
5.2 Radiofrequency (RF) ablators
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Electrical ablators
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Cryoablation devices
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5 Ultrasound ablators
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6 Others
5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Cardiac Ablation Market, By Approach
6.1 Key segment trends
6.2 Catheter-based
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Open/surgical
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Cardiac Ablation Devices Market, By Application
7.1 Key segment trends
7.2 Atrial Fibrillation & Flutter
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Tachycardia
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Others
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Cardiac Ablation Market, By End-use
8.1 Key segment trends
8.2 Hospitals
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Ambulatory surgical centers
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Cardiac centers
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Others
8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Cardiac Ablation Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Russia
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Abbott Laboratories (St. Jude Medical)
10.2 AngioDynamics, Inc.
10.3 AtriCure Inc
10.4 Biosense Webster (Johnson & Johnson)
10.5 Biotronik SE & Co. KG.
10.6 Boston Scientific Corporation
10.7 Japan Lifeline
10.8 Medtronic plc
10.9 Microport Scientific Corporation
10.10 Stereotaxis, Inc.
